A possible role for humoral immunity in the pathogenesis of Parkinson's disease.
about
The immunoregulatory role of dopamine: an updateSystems medicine: the future of medical genomics and healthcareTargeting microglial K(ATP) channels to treat neurodegenerative diseases: a mitochondrial issueThe role of the immune system in neurodegenerative disorders: Adaptive or maladaptive?New immunological approaches in treating and diagnosing CNS diseasesVaccination strategies for Parkinson disease: induction of a swift attack or raising tolerance?Sex differences in Parkinson's diseaseNeuroimmunological processes in Parkinson's disease and their relation to α-synuclein: microglia as the referee between neuronal processes and peripheral immunityMicroglia development and functionParkinson's disease as a result of agingImmunolocalization of influenza A virus and markers of inflammation in the human Parkinson's disease brainPhosphodiesterase 7 inhibition preserves dopaminergic neurons in cellular and rodent models of Parkinson diseaseCommon genetic variation in the HLA region is associated with late-onset sporadic Parkinson's disease.Leukocyte-subset counts in idiopathic parkinsonism provide clues to a pathogenic pathway involving small intestinal bacterial overgrowth. A surveillance study.Involvement of Fc receptors in disorders of the central nervous system.α-synuclein reactive antibodies as diagnostic biomarkers in blood sera of Parkinson's disease patients.Neuromelanin is an immune stimulator for dendritic cells in vitro.Ascorbic acid prevents blood-brain barrier disruption and sensory deficit caused by sustained compression of primary somatosensory cortexFcγ receptors are required for NF-κB signaling, microglial activation and dopaminergic neurodegeneration in an AAV-synuclein mouse model of Parkinson's disease.The genetics of Parkinson disease.Autoantibodies to alpha-synuclein in inherited Parkinson's disease.Involvement of the Fc gamma receptor in a chronic N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of dopaminergic loss.Generation of reactive oxygen species in 1-methyl-4-phenylpyridinium (MPP+) treated dopaminergic neurons occurs as an NADPH oxidase-dependent two-wave cascade.Role of α-synuclein in inducing innate and adaptive immunity in Parkinson disease.Biomarker candidates of neurodegeneration in Parkinson's disease for the evaluation of disease-modifying therapeuticsPeripheral aetiopathogenic drivers and mediators of Parkinson's disease and co-morbidities: role of gastrointestinal microbiota.Markers of inflammation in prevalent and incident Parkinson's disease in the Cardiovascular Health StudyFractalkine Signaling Regulates the Inflammatory Response in an α-Synuclein Model of Parkinson Disease.Aspects of innate immunity and Parkinson's disease.Dimebon slows progression of proteinopathy in γ-synuclein transgenic mice.Peripheral vs. Central Sex Steroid Hormones in Experimental Parkinson's Disease.Blood biomarker for Parkinson disease: peptoids.Intermittent theta-burst stimulation rescues dopamine-dependent corticostriatal synaptic plasticity and motor behavior in experimental parkinsonism: Possible role of glial activity.Impact of intravenous immunoglobulin on the dopaminergic system and immune response in the acute MPTP mouse model of Parkinson's diseaseEmerging drugs for Parkinson's disease.Human serum antibodies against EBV latent membrane protein 1 cross-react with α-synuclein.The Lewy body in Parkinson's disease: molecules implicated in the formation and degradation of alpha-synuclein aggregates.Antineuronal antibodies in Parkinson's disease.Telomere shortening leads to an acceleration of synucleinopathy and impaired microglia response in a genetic mouse model.Immunological features of alpha-synuclein in Parkinson's disease.
P2860
Q22252519-BC577D4C-2831-4CE4-AE20-90B2A28A4C75Q24288895-86438F81-53F7-4CDA-9FC2-9B18E45D91CCQ26852041-D4941480-B33E-4BC6-AC6A-D356466D4E21Q26861263-92FEA61E-8EAB-41A2-9C76-0C1116589BFAQ26865204-367ACC8B-BC7F-47D0-B6A8-E3EA39BEBE15Q27015811-7274FDC0-CFD3-4494-BEC3-95AEE2374D2EQ27025107-CE880790-D43A-4F67-AD59-F9289383DF50Q27027973-D26756A9-4078-4043-A952-34297A893383Q27316453-ED7EEE6D-0A20-44E2-886C-F9B7136825C3Q28084395-C5FE1676-3FDA-43E6-9B30-537C6340F5EAQ28478382-94A6E9F8-E529-42D6-ABA4-E8927AA327A8Q28742424-F4D052F4-6E1F-4D08-A866-14F57163AAD2Q28943440-0234F0C4-1D9A-44F1-9BDE-587993A6B242Q30528442-21B087B7-68BC-4AB5-906C-EB2239B74DD0Q33886574-EA646825-A24B-4864-8161-9E5B98762F05Q33889446-B3A32480-BA7B-499F-9953-FD45B7743984Q34074838-94226C19-75C4-4927-978B-3A40320CA4AEQ34171116-3551A97E-C99F-4940-BB50-9D77E6D722A5Q34287439-FBCC0170-EA23-44DF-80E8-BC83A23F4224Q34604083-4D77809F-A62C-43DE-89BA-3A7F751972B2Q35159805-45186948-190A-4133-B0BE-EC0A7282D13BQ35309412-A1715ECE-1723-48BB-9D96-CD5878EAECD2Q35416073-B967353B-3D5E-41D7-B86C-84C55AB1CEF1Q35510197-7E7905C6-DD3F-4FCF-BAD3-A282798F3BE4Q35649302-B6B9CC4B-21F2-4241-B1D5-FF024291CF50Q35669153-4283EA43-B23B-43B3-8D15-7C69D5513696Q35785450-C963F714-EE07-4EE7-AF6B-940E9C872166Q35808359-3AD66B47-F2CD-4745-941A-9489A22830CFQ35813131-71A88FC5-A8B8-4799-AAD6-6E6AEC30758EQ35957568-59E1D8BC-5954-4B41-82B3-8D84AF88E2B7Q35971342-87488C36-6B4F-4857-9011-F07A071274AFQ36182485-49D0EBDA-1D7F-4F58-9DB5-72CD52CBF2BCQ36341914-8FB85169-D145-4F6B-9B4F-B94608458922Q36462680-BA2B3593-8045-4E7F-96C0-7A17FB5A6F1AQ36580572-8E4A141F-F7FF-46F9-BEBD-16BCA56D21E6Q36894433-FC40DD76-CF1E-497A-8E8E-77E5F8DA5494Q37003482-089518CA-4B64-47F7-94A1-47C5FFF4351EQ37126355-B5E19E69-D5B0-40ED-9562-77C0A0930B62Q37196069-46A85373-5AE6-4DBF-BBD1-CEF52C6B65EAQ37232067-87FBE05C-6000-44AF-8997-EEED5D9F27B5
P2860
A possible role for humoral immunity in the pathogenesis of Parkinson's disease.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
A possible role for humoral immunity in the pathogenesis of Parkinson's disease.
@en
A possible role for humoral immunity in the pathogenesis of Parkinson's disease.
@nl
type
label
A possible role for humoral immunity in the pathogenesis of Parkinson's disease.
@en
A possible role for humoral immunity in the pathogenesis of Parkinson's disease.
@nl
prefLabel
A possible role for humoral immunity in the pathogenesis of Parkinson's disease.
@en
A possible role for humoral immunity in the pathogenesis of Parkinson's disease.
@nl
P2860
P50
P356
P1433
P1476
A possible role for humoral immunity in the pathogenesis of Parkinson's disease.
@en
P2093
Hideo Mori
P2860
P304
P356
10.1093/BRAIN/AWH625
P407
P577
2005-10-11T00:00:00Z